| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Benign Prostatic Hyperplasia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hyperplasia | |||||
| Prostatic Hyperplasia | |||||
| 3 | More general conditions related to this trial | ||||
| Genital Diseases, Male | |||||
| Pathologic Processes | |||||
| Prostatic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Finasteride and Alfuzosin | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Alfuzosin | |||||
| Finasteride | |||||
| 6 | More general drug interventions related to this trial | ||||
| Adrenergic Agents | |||||
| Adrenergic alpha-Antagonists | |||||
| Adrenergic Antagonists | |||||
| Antihypertensive Agents | |||||
| Cardiovascular Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| Diagnostic Ultrasound | |||||
| Urologix | |||||
| Medtronic | |||||
| Merck | |||||
| Sanofi-Synthelabo | |||||
|
